MedPath

ImmunoBoost: The Lymphatic Osteopathic Manipulative Treatment Protocol Study

Not Applicable
Not yet recruiting
Conditions
Healthy
Registration Number
NCT06565065
Lead Sponsor
Western University of Health Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Not yet recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria

Inclusion Criteria:<br><br> - Individuals must be 18 years or older.<br><br> - Individuals must provide informed consent.<br><br> - Individuals must be healthy with a BMI under 30, with no primary or secondary immune<br> deficiency or autoimmune disease/must not be immunocompromised.<br><br> - Individuals must not be using or recently have used any immune-altering medications<br> such as corticosteroids, cyclosporin, tacrolimus, and pimecrolimus<br><br> - Individuals must not have had lymphatic OMT or other physical manipulation such as<br> acupuncture, physical therapy, chiropractic, or massage therapy in the previous four<br> weeks before study enrollment.<br><br> - Individuals must have the ability to receive OMT with lymphatic techniques.<br><br> - Individuals must be able to tolerate 12 minutes of moderate physical activity.<br><br> - Individuals must not be pregnant or breastfeeding.<br><br> - Individuals must not have had a splenectomy or other spleen or oncologic surgery<br> within the past 6 months.<br><br> - Individuals must be infection-free for the past 6 weeks before starting the study<br> and have not received any immunizations within the past 6 weeks.<br><br> - Individuals must be willing to avoid strenuous activity at least 24 hours before<br> each visit.<br><br> - Individuals must be willing to abstain from moderate to intense activity in the 4<br> hours between their 2nd blood draw and their final blood draw at each of their three<br> visits.<br><br>Exclusion Criteria:<br><br> - Individuals are younger than 18 years of age.<br><br> - Individuals who do not provide informed consent.<br><br> - Individuals with a BMI over 30, or with primary or secondary immune deficiency or<br> autoimmune disease or is immunocompromised.<br><br> - Individuals using or recently have used any immune-altering medications such as<br> corticosteroids, cyclosporin, tacrolimus, and pimecrolimus<br><br> - Individuals who have had lymphatic OMT or other physical manipulation such as<br> acupuncture, physical therapy, chiropractic, or massage therapy in the previous four<br> weeks before study enrollment.<br><br> - Individuals who don't have the ability to receive OMT with lymphatic techniques.<br><br> - Individuals who cannot tolerate 12 minutes of moderate physical activity.<br><br> - Individuals who are pregnant or breastfeeding.<br><br> - Individuals who have had a splenectomy or other spleen or oncologic surgery within<br> the past 6 months.<br><br> - Individuals who have had an infection in the 6 weeks before starting the study and<br> or have received any immunizations within the past 6 weeks.<br><br> - Individuals not willing to avoid strenuous activity at least 24 hours before each<br> visit.<br><br> - Individuals not willing to abstain from moderate to intense activity in the 4 hours<br> between their 2nd blood draw and their final blood draw at each of their three<br> visits.

Exclusion Criteria

Not provided

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Complete Blood Count (CBC) with differential
Secondary Outcome Measures
NameTimeMethod
Pro-Inflammatory cytokine profiling;Evaluation of safety based on reported adverse events
© Copyright 2025. All Rights Reserved by MedPath